| Tumor hypoxia and radiotherapy: A major driver of resistance even for novel radiotherapy modalities C Beckers, M Pruschy, I Vetrugno Seminars in Cancer Biology 98, 19-30, 2024 | 40 | 2024 |
| Targeting the survival kinase DYRK1B: A novel approach to overcome radiotherapy-related treatment resistance C Beckers, L Vasilikos, AS Fernandez, L Moor, M Pruschy Radiotherapy and Oncology 190, 110039, 2024 | 7 | 2024 |
| (–)-N-3-Benzylphenobarbital Is Superior to Omeprazole and (+)-N-3-Benzylnirvanol as a CYP2C19 Inhibitor in Suspended Human Hepatocytes ML Cuypers, H Chanteux, E Gillent, P Bonnaillie, K Saunders, C Beckers, ... Drug Metabolism and Disposition 48 (11), 1121-1128, 2020 | 3 | 2020 |
| Live-cell imaging and analysis of 3D spheroids in hypoxia-and radiotherapy-related research C Beckers, L Vasilikos, L Moor, M Pruschy Clinical and Translational Radiation Oncology 51, 100920, 2025 | | 2025 |
| Mitochondria-targeted antioxidant MitoQ radiosensitizes tumors by decreasing mitochondrial oxygen consumption JD Rondeau, S Lipari, B Mathieu, C Beckers, JA Van de Velde, L Mignion, ... Cell Death Discovery 10 (1), 514, 2024 | | 2024 |
| Catalytically Active Ti‐Based Nanomaterials for Hydroxyl Radical Mediated Clinical X‐Ray Enhancement LRH Gerken, C Beckers, BA Brugger, VM Kissling, A Gogos, S Wee, ... Advanced Science 11 (47), 2406198, 2024 | | 2024 |
| Targeting Survival Pathways to Overcome Hypoxia-Driven Radioresistance C Beckers University of Zurich, 2024 | | 2024 |
| Targeting hypoxic survival pathways to overcome radiotherapy-related treatment resistance C Beckers, L Vasilikos, A Sanchez-Fernandez, L Moor, M Pruschy Cancer Research 84 (6_Supplement), 704-704, 2024 | | 2024 |
| Determination of plasma 25 hydroxycholecalciferol by competition A Baret, B Mathieu, PL Desbene, PJ Ceyte, JL Morcellet, C Beckers Centre d'Etudes et de Recherches Biophysiologiques, Toulon, France, 1973 | | 1973 |
